Nichols Weston's Form 4 filing
TScan Therapeutics, Inc. (TCRX) · filed Dec 23, 2025
- Accession no.
- 0000902664-25-005396
- Filed
- Dec 23, 2025, 6:17 PM ET
- Trade date
- Dec 19-23, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $145.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols WestonCIK 0001746376 | 10% Owner |
| Lynx1 Capital Management LPCIK 0001910456 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common stock, $0.0001 par value per share ("Common Stock") | PPurchaseAcquired | +80,069 | $0.8989 | +$71,974.02 | 7,937,416 | Indirect | |
| Dec 22, 2025 | Common Stock | PPurchaseAcquired | +75,500 | $0.90 | +$67,950 | 8,012,916 | Indirect | |
| Dec 23, 2025 | Common Stock | PPurchaseAcquired | +6,232 | $0.8989 | +$5,601.94 | 8,019,148 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.